Recent Quarter Total Invested
$89.68 M
Recent Quarter Institutional Ownership Percentage
68.35%
Total Invested of Last Quarter
$63.74 M
Ownership Percentage of Last Quarter
83.82%
Jasper Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2024 | 11.22 M | $8.55 M | 0.00% | 10.23% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2024 | 9.87 M | $7.79 M | 18.91% | 9.00% |
CARLYLE GROUP INC. | 02/02/2024 | 8.76 M | $6.67 M | 0.00% | 7.99% |
QIMING U.S. VENTURES MANAGEMENT, LLC | 02/14/2024 | 8.52 M | $6.72 M | 0.00% | 7.76% |
OCTAGON CAPITAL ADVISORS LP | 02/14/2024 | 4.47 M | $3.53 M | 0.00% | 4.07% |
VANGUARD GROUP INC | 03/11/2024 | 4.09 M | $3.23 M | 7.91% | 3.73% |
OPALEYE MANAGEMENT INC. | 02/14/2024 | 3.99 M | $3.14 M | 100.00% | 3.63% |
ALLY BRIDGE GROUP (NY) LLC | 02/14/2024 | 3.66 M | $28.87 M | 16.38% | 3.34% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 03/18/2024 | 3.54 M | $2.79 M | 16.45% | 3.23% |
BANK OF AMERICA CORP /DE/ | 02/14/2024 | 3.18 M | $2.51 M | -0.01% | 2.90% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 02/15/2024 | 2.23 M | $1.76 M | -7.27% | 2.03% |
WOODLINE PARTNERS LP | 02/14/2024 | 1.73 M | $1.37 M | -42.23% | 1.58% |
MORGAN STANLEY | 08/16/2024 | 1.70 M | $1.34 M | 117.65% | 1.55% |
SATURN V CAPITAL MANAGEMENT LLC | 02/14/2024 | 1.39 M | $1.09 M | -0.06% | 1.26% |
BLACKROCK INC. | 02/13/2024 | 1.32 M | $1.04 M | 0.24% | 1.21% |
GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 904,477 | $713,779 | 0.00% | 0.82% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 02/05/2024 | 789,331 | $622,782 | 100.00% | 0.72% |
SPHERA FUNDS MANAGEMENT LTD. | 02/15/2024 | 713,063 | $5.63 M | -87.46% | 0.65% |
MARINER, LLC | 02/14/2024 | 590,510 | $465,912 | -9.53% | 0.54% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 514,324 | $406,000 | 65.80% | 0.47% |
BANK OF MONTREAL /CAN/ | 02/08/2024 | 348,300 | $278,640 | 100.00% | 0.32% |
MONACO ASSET MANAGEMENT SAM | 02/07/2024 | 249,563 | $196,905 | 100.00% | 0.23% |
STATE STREET CORP | 02/14/2024 | 229,994 | $181,465 | 0.00% | 0.21% |
COWEN AND COMPANY, LLC | 02/12/2024 | 200,000 | $157,800 | -0.20% | 0.18% |
CITADEL ADVISORS LLC | 02/14/2024 | 191,155 | $150,821 | 144.05% | 0.17% |
NORTHERN TRUST CORP | 02/13/2024 | 154,909 | $122,223 | 0.00% | 0.14% |
MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 129,883 | $102,478 | 108.45% | 0.12% |
SUMMIT TRAIL ADVISORS, LLC | 02/06/2024 | 65,000 | $51,285 | 0.00% | 0.06% |
IEQ CAPITAL, LLC | 02/07/2024 | 54,500 | $43,001 | 100.00% | 0.05% |
TWO SIGMA INVESTMENTS, LP | 02/14/2024 | 54,168 | $42,739 | -18.04% | 0.05% |
BANK OF NEW YORK MELLON CORP | 01/29/2024 | 43,593 | $34,395 | 0.00% | 0.04% |
CITADEL ADVISORS LLC | 02/14/2024 | 39,200 | $30,929 | -43.11% | 0.04% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2024 | 36,899 | $29,113 | 0.00% | 0.03% |
GRIES FINANCIAL LLC | 02/13/2024 | 23,845 | $18,814 | 0.00% | 0.02% |
LAZARD ASSET MANAGEMENT LLC | 02/14/2024 | 11,500 | $8,000 | 3.23% | 0.01% |
JANE STREET GROUP, LLC | 02/15/2024 | 11,209 | $8,844 | 100.00% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2024 | 11,144 | $8,793 | 100.00% | 0.01% |
WELLS FARGO & COMPANY/MN | 02/09/2024 | 609 | $481 | -18.69% | 0.00% |
GROUP ONE TRADING, L.P. | 02/14/2024 | 1 | $1 | 0.00% | 0.00% |
FRANKLIN RESOURCES INC | 02/09/2024 | 0 | $0 | -100.00% | 0.00% |
FMR LLC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
BVF INC/IL | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
SCOGGIN MANAGEMENT LP | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
FERNWOOD INVESTMENT MANAGEMENT, LLC | 02/05/2024 | 0 | $0 | -100.00% | 0.00% |
FOREFRONT ANALYTICS, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
ALTIUM CAPITAL MANAGEMENT LP | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
IKARIAN CAPITAL, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
Jasper Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of JSPR shares?
During the previous two years, 3 institutional investors and hedge funds held shares of Jasper Therapeutics, Inc.. The most heavily invested institutionals were:
One68 Global Capital, LLC: 20,000
Abingworth LLP: 5.63 M
Grace Capital: 218,110
-
What percentage of Jasper Therapeutics, Inc. stock is owned by institutional investors?
68.35% of Jasper Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at JSPR ?
Institutional investors have bought a total of 5.87 M shares in the last 24 months. This purchase volume represents approximately $117.69 M in transactions.